1.77  -0.06 (-3.28%)		03-20 16:00
Open: 1.805 High: 1.86 Volume: 487,985		Pre. Close: 1.83 Low: 1.735 Market Cap: 51(M)

Short term
Mid term
Targets	6-month :	2.22	1-year :	2.41
Resists	First :	1.9	Second :	2.06
Pivot price	1.83
Supports	First :	1.62	Second :	1.35
MAs	MA(5) :	1.86	MA(20) :	1.82
	MA(100) :	2.47	MA(250) :	5.54
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	32.8	D(3) :	45.8
RSI	RSI(14): 44.5
52-week	High :	64.8	Low :	1.41

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ STSS ] has closed above bottom band by 18.7%. Bollinger Bands are 79.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 23 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	1.86 - 1.87	1.87 - 1.88
Low:	1.71 - 1.72	1.72 - 1.73
Close:	1.75 - 1.77	1.77 - 1.78

Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.

Thu, 19 Mar 2026
Sharps Technology (STSS) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

Wed, 04 Mar 2026
Sharps Technology, Inc. (NASDAQ:STSS) Short Interest Update - MarketBeat

Wed, 25 Feb 2026
Why a medical device company is delegating 2M+ SOL to The Tie - Stock Titan

Mon, 26 Jan 2026
Sharps Technology posts first update on Solana staking income amid SOL price slump - The Block

Mon, 26 Jan 2026
This medical device firm is earning ~7% a year staking Solana - Stock Titan

Mon, 17 Nov 2025
Sharps Technology stock sinks to record low after debut Solana-treasury quarterly filing - The Block

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares Out	0 (M)
Shares Float	29 (M)
Held by Insiders	2.033e+007 (%)
Held by Institutions	7.3 (%)
Shares Short	563 (K)
Shares Short P.Month	0 (K)

EPS	-1.181e+008
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	-131 %
Return on Assets (ttm)	347.6 %
Return on Equity (ttm)	-32.6 %
Qtrly Rev. Growth	306340 %
Gross Profit (p.s.)	0
Sales Per Share	-21.58
EBITDA (p.s.)	-1e+006
Qtrly Earnings Growth	-873.3 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-14 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	-0.09
Price to Cash Flow	0.24

Dividend	0
Forward Dividend	516280
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.